US 10160795
Neutralizing antibodies to Ebola virus glycoprotein and their use
granted A61KA61K2039/505
Quick answer
US patent 10160795 (Neutralizing antibodies to Ebola virus glycoprotein and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 39
- CPC classes
- A61K, A61K2039/505